MGV vs XLV
Vanguard Mega Cap Value ETF vs Health Care Select Sector SPDR Fund
- • MGV has the lower expense ratio at 0.05% vs 0.08% for XLV.
- • MGV pays a higher dividend yield (1.82%).
Side-by-side metrics
| Metric | MGV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.82% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $14.39B | $49.10B |
YTD return | 21.01% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.63 | 0.41 |
P/E ratio | 21.02 | 30.63 |
Last price | $170.26 | $187.94 |
Inception | — | — |
Issuer | Vanguard | State Street |
MGV top holdings
| MU | Micron Technology Inc | 5.91% |
| JPM | JPMorgan Chase & Co | 4.32% |
| BRK-B | Berkshire Hathaway Inc Class B | 3.46% |
| XOM | ExxonMobil Holdings Corp | 3.31% |
| JNJ | Johnson & Johnson | 3.13% |
| ABBV | AbbVie Inc | 2.27% |
| WMT | Walmart Inc | 2.23% |
| COST | Costco Wholesale Corp | 1.98% |
| CVX | Chevron Corp | 1.88% |
| CSCO | Cisco Systems Inc | 1.88% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About MGV
MGV (Vanguard Mega Cap Value ETF) is Mega-cap US value stocks. Managed by Vanguard, the fund carries $14.4B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.82%. Its largest holding is Micron Technology Inc (MU), which represents 5.9% of the portfolio. Real Estate is the fund's largest sector exposure at 1.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.